
REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19
Experience design We are conducting an operationally seamless (continuous enrollment) multicenter, randomized, double-blind, placebo-controlled, phase 1–3 clinical trial involving asymptomatic non-hospitalized patients with Covid-19. The..